Class III

Drug Recall: Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20

Novitium Pharma LLC · March 4, 2024

Reason for Recall

Cross Contamination with Other Products:(mycophenolate mofetil).

Distribution

Nationwide in the USA

States Affected

NATIONWIDE

Quantity Affected

3,940 1000-count bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0389-2024

Status: terminated

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.